{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:59:12Z","timestamp":1790819952666,"version":"4.1.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Synaptic loss, plaques and neurofibrillary tangles are viewed as hallmarks of Alzheimer\u2019s disease (AD). This study investigated synaptic markers in neocortical Brodmann area 9 (BA9) samples from 171 subjects with and without AD at different levels of cognitive impairment. The expression levels of vesicular glutamate transporters (VGLUT1&amp;2), glutamate uptake site (EAAT2), post-synaptic density protein of 95 kD (PSD95), vesicular GABA\/glycine transporter (VIAAT), somatostatin (som), synaptophysin and choline acetyl transferase (ChAT) were evaluated. VGLUT2 and EAAT2 were unaffected by dementia. The VGLUT1, PSD95, VIAAT, som, ChAT and synaptophysin expression levels significantly decreased as dementia progressed. The maximal decrease varied between 12% (synaptophysin) and 42% (som). VGLUT1 was more strongly correlated with dementia than all of the other markers (polyserial correlation\u2009=\u2009\u22120.41). Principal component analysis using these markers was unable to differentiate the CDR groups from one another. Therefore, the status of the major synaptic markers in BA9 does not seem to be linked to the cognitive status of AD patients. The findings of this study suggest that the loss of synaptic markers in BA9 is a late event that is only weakly related to AD dementia.<\/jats:p>","DOI":"10.1038\/s41598-018-19154-y","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T12:25:25Z","timestamp":1515673525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Moderate decline in select synaptic markers in the prefrontal cortex (BA9) of patients with Alzheimer\u2019s disease at various cognitive stages"],"prefix":"10.1038","volume":"8","author":[{"given":"Odile","family":"Poirel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Mella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Videau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauriane","family":"Ramet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Davoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0058-6959","authenticated-orcid":false,"given":"Etienne","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Katsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naguib","family":"Mechawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahram","family":"Haroutunian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Epelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7048-7617","authenticated-orcid":false,"given":"St\u00e9phanie","family":"Daumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah","family":"El Mestikawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,17]]},"reference":[{"key":"19154_CR1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.advms.2014.11.002","volume":"60","author":"P Lewczuk","year":"2015","unstructured":"Lewczuk, P., Mroczko, B., Fagan, A. & Kornhuber, J. Biomarkers of Alzheimer\u2019s disease and mild cognitive impairment: a current perspective. Adv Med Sci 60, 76\u201382 (2015).","journal-title":"Adv Med Sci"},{"key":"19154_CR2","first-page":"1512","volume":"70","author":"M Wirth","year":"2013","unstructured":"Wirth, M. et al. Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people. JAMA Neurol 70, 1512\u20131519 (2013).","journal-title":"JAMA Neurol"},{"issue":"1125","key":"19154_CR3","first-page":"e1121","volume":"33","author":"MS Beeri","year":"2012","unstructured":"Beeri, M. S. et al. Synaptic protein deficits are associated with dementia irrespective of extreme old age. Neurobiol Aging 33(1125), e1121\u20131128 (2012).","journal-title":"Neurobiol Aging"},{"key":"19154_CR4","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.neurobiolaging.2012.11.024","volume":"34","author":"NC Berchtold","year":"2013","unstructured":"Berchtold, N. C. et al. Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer\u2019s disease. Neurobiol Aging 34, 1653\u20131661 (2013).","journal-title":"Neurobiol Aging"},{"key":"19154_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ana.410270502","volume":"27","author":"ST DeKosky","year":"1990","unstructured":"DeKosky, S. T. & Scheff, S. W. Synapse loss in frontal cortex biopsies in Alzheimer\u2019s disease: correlation with cognitive severity. Ann Neurol 27, 457\u2013464 (1990).","journal-title":"Ann Neurol"},{"key":"19154_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","volume":"118","author":"C Duyckaerts","year":"2009","unstructured":"Duyckaerts, C., Delatour, B. & Potier, M. C. Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118, 5\u201336 (2009).","journal-title":"Acta Neuropathol"},{"key":"19154_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0197-4580(90)90059-9","volume":"11","author":"SW Scheff","year":"1990","unstructured":"Scheff, S. W., DeKosky, S. T. & Price, D. A. Quantitative assessment of cortical synaptic density in Alzheimer\u2019s disease. Neurobiol Aging 11, 29\u201337 (1990).","journal-title":"Neurobiol Aging"},{"key":"19154_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3233\/JAD-2006-9S312","volume":"9","author":"SW Scheff","year":"2006","unstructured":"Scheff, S. W. & Price, D. A. Alzheimer\u2019s disease-related alterations in synaptic density: neocortex and hippocampus. J Alzheimers Dis 9, 101\u2013115 (2006).","journal-title":"J Alzheimers Dis"},{"key":"19154_CR9","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","volume":"27","author":"SW Scheff","year":"2006","unstructured":"Scheff, S. W., Price, D. A., Schmitt, F. A. & Mufson, E. J. Hippocampal synaptic loss in early Alzheimer\u2019s disease and mild cognitive impairment. Neurobiol Aging 27, 1372\u20131384 (2006).","journal-title":"Neurobiol Aging"},{"key":"19154_CR10","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry, R. D. et al. Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30, 572\u2013580 (1991).","journal-title":"Ann Neurol"},{"key":"19154_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0969-9961(02)00009-8","volume":"12","author":"PJ Yao","year":"2003","unstructured":"Yao, P. J. et al. Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer\u2019s disease. Neurobiol Dis 12, 97\u2013109 (2003).","journal-title":"Neurobiol Dis"},{"key":"19154_CR12","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jalz.2015.12.005","volume":"12","author":"MC de Wilde","year":"2016","unstructured":"de Wilde, M. C., Overk, C. R., Sijben, J. W. & Masliah, E. Meta-analysis of synaptic pathology in Alzheimer\u2019s disease reveals selective molecular vesicular machinery vulnerability. Alzheimers Dement 12, 633\u2013644 (2016).","journal-title":"Alzheimers Dement"},{"key":"19154_CR13","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.bcp.2013.12.028","volume":"88","author":"SW Scheff","year":"2014","unstructured":"Scheff, S. W., Neltner, J. H. & Nelson, P. T. Is synaptic loss a unique hallmark of Alzheimer\u2019s disease? Biochem Pharmacol 88, 517\u2013528 (2014).","journal-title":"Biochem Pharmacol"},{"key":"19154_CR14","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.neurobiolaging.2003.04.005","volume":"24","author":"WG Honer","year":"2003","unstructured":"Honer, W. G. Pathology of presynaptic proteins in Alzheimer\u2019s disease: more than simple loss of terminals. Neurobiol Aging 24, 1047\u20131062 (2003).","journal-title":"Neurobiol Aging"},{"key":"19154_CR15","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1046\/j.1460-9568.2000.00164.x","volume":"12","author":"T Harkany","year":"2000","unstructured":"Harkany, T. et al. beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis. Eur J Neurosci 12, 2735\u20132745 (2000).","journal-title":"Eur J Neurosci"},{"key":"19154_CR16","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1126\/science.164.3880.719","volume":"164","author":"JW Olney","year":"1969","unstructured":"Olney, J. W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164, 719\u2013721 (1969).","journal-title":"Science"},{"key":"19154_CR17","doi-asserted-by":"publisher","first-page":"e43201","DOI":"10.1371\/journal.pone.0043201","volume":"7","author":"CL Russell","year":"2012","unstructured":"Russell, C. L. et al. Amyloid-beta acts as a regulator of neurotransmitter release disrupting the interaction between synaptophysin and VAMP2. PLoS One 7, e43201 (2012).","journal-title":"PLoS One"},{"key":"19154_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.neuint.2007.03.012","volume":"51","author":"AL Sheldon","year":"2007","unstructured":"Sheldon, A. L. & Robinson, M. B. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int 51, 333\u2013355 (2007).","journal-title":"Neurochem Int"},{"key":"19154_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1084\/jem.20140413","volume":"212","author":"K Takahashi","year":"2015","unstructured":"Takahashi, K. et al. Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer\u2019s disease. J Exp Med 212, 319\u2013332 (2015).","journal-title":"J Exp Med"},{"key":"19154_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","volume":"65","author":"NC Danbolt","year":"2001","unstructured":"Danbolt, N. C. Glutamate uptake. Prog Neurobiol 65, 1\u2013105 (2001).","journal-title":"Prog Neurobiol"},{"key":"19154_CR21","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/sj.mp.4002065","volume":"12","author":"TL Lauriat","year":"2007","unstructured":"Lauriat, T. L. & McInnes, L. A. EAAT2 regulation and splicing: relevance to psychiatric and neurological disorders. Mol Psychiatry 12, 1065\u20131078 (2007).","journal-title":"Mol Psychiatry"},{"key":"19154_CR22","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0896-6273(00)80086-0","volume":"16","author":"JD Rothstein","year":"1996","unstructured":"Rothstein, J. D. et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16, 675\u2013686 (1996).","journal-title":"Neuron"},{"key":"19154_CR23","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3233\/JAD-2011-110002","volume":"26","author":"KH Chen","year":"2011","unstructured":"Chen, K. H., Reese, E. A., Kim, H. W., Rapoport, S. I. & Rao, J. S. Disturbed neurotransmitter transporter expression in Alzheimer\u2019s disease brain. J Alzheimers Dis 26, 755\u2013766 (2011).","journal-title":"J Alzheimers Dis"},{"key":"19154_CR24","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/ana.410400512","volume":"40","author":"E Masliah","year":"1996","unstructured":"Masliah, E., Alford, M., DeTeresa, R., Mallory, M. & Hansen, L. Deficient glutamate transport is associated with neurodegeneration in Alzheimer\u2019s disease. Ann Neurol 40, 759\u2013766 (1996).","journal-title":"Ann Neurol"},{"key":"19154_CR25","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1046\/j.1471-4159.1995.64052193.x","volume":"64","author":"HL Scott","year":"1995","unstructured":"Scott, H. L., Tannenberg, A. E. & Dodd, P. R. Variant forms of neuronal glutamate transporter sites in Alzheimer\u2019s disease cerebral cortex. J Neurochem 64, 2193\u20132202 (1995).","journal-title":"J Neurochem"},{"key":"19154_CR26","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.1471-4159.2006.03935.x","volume":"98","author":"SL Kirvell","year":"2006","unstructured":"Kirvell, S. L., Esiri, M. & Francis, P. T. Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer\u2019s disease. J Neurochem 98, 939\u2013950 (2006).","journal-title":"J Neurochem"},{"issue":"Pt A","key":"19154_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neuropharm.2013.08.026","volume":"76","author":"PM Canas","year":"2014","unstructured":"Canas, P. M., Simoes, A. P., Rodrigues, R. J. & Cunha, R. A. Predominant loss of glutamatergic terminal markers in a beta-amyloid peptide model of Alzheimer\u2019s disease. Neuropharmacology 76(Pt A), 51\u201356 (2014).","journal-title":"Neuropharmacology"},{"key":"19154_CR28","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.neurobiolaging.2005.09.034","volume":"27","author":"KF Bell","year":"2006","unstructured":"Bell, K. F. et al. The amyloid pathology progresses in a neurotransmitter-specific manner. Neurobiol Aging 27, 1644\u20131657 (2006).","journal-title":"Neurobiol Aging"},{"key":"19154_CR29","doi-asserted-by":"crossref","unstructured":"El Mestikawy, S., Wallen-Mackenzie, A., Fortin, G. M., Descarries, L. & Trudeau, L. E. From glutamate co-release to vesicular synergy: vesicular glutamate transporters. Nat Rev Neurosci 12, 204\u2013216.","DOI":"10.1038\/nrn2969"},{"key":"19154_CR30","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.neurobiolaging.2007.04.010","volume":"29","author":"A Kashani","year":"2008","unstructured":"Kashani, A. et al. Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease. Neurobiol Aging 29, 1619\u20131630 (2008).","journal-title":"Neurobiol Aging"},{"key":"19154_CR31","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1177\/1533317511421780","volume":"26","author":"N Fayed","year":"2011","unstructured":"Fayed, N., Modrego, P. J., Rojas-Salinas, G. & Aguilar, K. Brain glutamate levels are decreased in Alzheimer\u2019s disease: a magnetic resonance spectroscopy study. Am J Alzheimers Dis Other Demen 26, 450\u2013456 (2011).","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"19154_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11915","volume":"7","author":"S Viana da Silva","year":"2016","unstructured":"Viana da Silva, S. et al. Early synaptic deficits in the APP\/PS1 mouse model of Alzheimer\u2019s disease involve neuronal adenosine A2A receptors. Nat Commun 7, 11915 (2016).","journal-title":"Nat Commun"},{"key":"19154_CR33","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/cercor\/bhp133","volume":"20","author":"D Balschun","year":"2010","unstructured":"Balschun, D. et al. Vesicular glutamate transporter VGLUT1 has a role in hippocampal long-term potentiation and spatial reversal learning. Cereb Cortex 20, 684\u2013693 (2010).","journal-title":"Cereb Cortex"},{"key":"19154_CR34","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0896-6273(00)81122-8","volume":"24","author":"R Janz","year":"1999","unstructured":"Janz, R. et al. Essential roles in synaptic plasticity for synaptogyrin I and synaptophysin I. Neuron 24, 687\u2013700 (1999).","journal-title":"Neuron"},{"key":"19154_CR35","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1523\/JNEUROSCI.2911-11.2012","volume":"32","author":"T Mishima","year":"2012","unstructured":"Mishima, T., Fujiwara, T., Kofuji, T. & Akagawa, K. Impairment of catecholamine systems during induction of long-term potentiation at hippocampal CA1 synapses in HPC-1\/syntaxin 1A knock-out mice. J Neurosci 32, 381\u2013389 (2012).","journal-title":"J Neurosci"},{"key":"19154_CR36","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1523\/JNEUROSCI.0282-16.2017","volume":"37","author":"L Ramet","year":"2017","unstructured":"Ramet, L. et al. Characterization of a Human Point Mutation of VGLUT3 (p.A211V) in the Rodent Brain Suggests a Nonuniform Distribution of the Transporter in Synaptic Vesicles. J Neurosci 37, 4181\u20134199 (2017).","journal-title":"J Neurosci"},{"key":"19154_CR37","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1046\/j.1471-4159.1995.64020749.x","volume":"64","author":"LM Bierer","year":"1995","unstructured":"Bierer, L. M. et al. Neurochemical correlates of dementia severity in Alzheimer\u2019s disease: relative importance of the cholinergic deficits. J Neurochem 64, 749\u2013760 (1995).","journal-title":"J Neurochem"},{"key":"19154_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.pneurobio.2009.07.002","volume":"89","author":"J Epelbaum","year":"2009","unstructured":"Epelbaum, J. et al. Somatostatin, Alzheimer\u2019s disease and cognition: an old story coming of age? Prog Neurobiol 89, 153\u2013161 (2009).","journal-title":"Prog Neurobiol"},{"key":"19154_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0304-3940(98)00698-3","volume":"255","author":"D Grouselle","year":"1998","unstructured":"Grouselle, D. et al. Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele. Neurosci Lett 255, 21\u201324 (1998).","journal-title":"Neurosci Lett"},{"key":"19154_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1056\/NEJM198507043130102","volume":"313","author":"PT Francis","year":"1985","unstructured":"Francis, P. T. et al. Neurochemical studies of early-onset Alzheimer\u2019s disease. Possible influence on treatment. N Engl J Med 313, 7\u201311 (1985).","journal-title":"N Engl J Med"},{"key":"19154_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1101\/lm.69204","volume":"11","author":"M Mesulam","year":"2004","unstructured":"Mesulam, M. The cholinergic lesion of Alzheimer\u2019s disease: pivotal factor or side show? Learn Mem 11, 43\u201349 (2004).","journal-title":"Learn Mem"},{"key":"19154_CR42","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/ana.20100","volume":"55","author":"M Mesulam","year":"2004","unstructured":"Mesulam, M., Shaw, P., Mash, D. & Weintraub, S. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol 55, 815\u2013828 (2004).","journal-title":"Ann Neurol"},{"issue":"Pt 3","key":"19154_CR43","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/brain\/122.3.383","volume":"122","author":"RJ Perry","year":"1999","unstructured":"Perry, R. J. & Hodges, J. R. Attention and executive deficits in Alzheimer\u2019s disease. A critical review. Brain 122(Pt 3), 383\u2013404 (1999).","journal-title":"Brain"},{"key":"19154_CR44","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bbr.2014.07.046","volume":"274","author":"V Parikh","year":"2014","unstructured":"Parikh, V., Bernard, C. S., Naughton, S. X. & Yegla, B. Interactions between Abeta oligomers and presynaptic cholinergic signaling: age-dependent effects on attentional capacities. Behav Brain Res 274, 30\u201342 (2014).","journal-title":"Behav Brain Res"},{"key":"19154_CR45","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/brain\/awv024","volume":"138","author":"A Baker-Nigh","year":"2015","unstructured":"Baker-Nigh, A. et al. Neuronal amyloid-beta accumulation within cholinergic basal forebrain in ageing and Alzheimer\u2019s disease. Brain 138, 1722\u20131737 (2015).","journal-title":"Brain"},{"key":"19154_CR46","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00401-010-0679-9","volume":"119","author":"GK Gouras","year":"2010","unstructured":"Gouras, G. K., Tampellini, D., Takahashi, R. H. & Capetillo-Zarate, E. Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer\u2019s disease. Acta Neuropathol 119, 523\u2013541 (2010).","journal-title":"Acta Neuropathol"},{"key":"19154_CR47","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nm.3639","volume":"20","author":"S Jo","year":"2014","unstructured":"Jo, S. et al. GABA from reactive astrocytes impairs memory in mouse models of Alzheimer\u2019s disease. Nat Med 20, 886\u2013896 (2014).","journal-title":"Nat Med"},{"key":"19154_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.nbd.2015.10.019","volume":"85","author":"M Lei","year":"2016","unstructured":"Lei, M. et al. Soluble Abeta oligomers impair hippocampal LTP by disrupting glutamatergic\/GABAergic balance. Neurobiol Dis 85, 111\u2013121 (2016).","journal-title":"Neurobiol Dis"},{"key":"19154_CR49","doi-asserted-by":"publisher","first-page":"E2895","DOI":"10.1073\/pnas.1121081109","volume":"109","author":"PE Sanchez","year":"2012","unstructured":"Sanchez, P. E. et al. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer\u2019s disease model. Proc Natl Acad Sci USA 109, E2895\u20132903 (2012).","journal-title":"Proc Natl Acad Sci USA"},{"key":"19154_CR50","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.cell.2012.02.046","volume":"149","author":"L Verret","year":"2012","unstructured":"Verret, L. et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 149, 708\u2013721 (2012).","journal-title":"Cell"},{"key":"19154_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fnana.2015.00023","volume":"9","author":"E Vigneault","year":"2015","unstructured":"Vigneault, E. et al. Distribution of vesicular glutamate transporters in the human brain. Front Neuroanat 9, 23 (2015).","journal-title":"Front Neuroanat"},{"key":"19154_CR52","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.neuron.2011.02.025","volume":"69","author":"E Fino","year":"2011","unstructured":"Fino, E. & Yuste, R. Dense inhibitory connectivity in neocortex. Neuron 69, 1188\u20131203 (2011).","journal-title":"Neuron"},{"key":"19154_CR53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1113\/jphysiol.2004.078915","volume":"562","author":"P Somogyi","year":"2005","unstructured":"Somogyi, P. & Klausberger, T. Defined types of cortical interneurone structure space and spike timing in the hippocampus. J Physiol 562, 9\u201326 (2005).","journal-title":"J Physiol"},{"key":"19154_CR54","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/nbt0308-303","volume":"26","author":"M Ringner","year":"2008","unstructured":"Ringner, M. What is principal component analysis? Nat Biotechnol 26, 303\u2013304 (2008).","journal-title":"Nat Biotechnol"},{"key":"19154_CR55","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neurobiolaging.2003.09.001","volume":"24","author":"PD Coleman","year":"2003","unstructured":"Coleman, P. D. & Yao, P. J. Synaptic slaughter in Alzheimer\u2019s disease. Neurobiol Aging 24, 1023\u20131027 (2003).","journal-title":"Neurobiol Aging"},{"key":"19154_CR56","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/cne.10760","volume":"463","author":"T Bussiere","year":"2003","unstructured":"Bussiere, T. et al. Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer\u2019s disease: stereologic analysis of prefrontal cortex area 9. J Comp Neurol 463, 281\u2013302 (2003).","journal-title":"J Comp Neurol"},{"key":"19154_CR57","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1749-6632.1995.tb38142.x","volume":"769","author":"AR Damasio","year":"1995","unstructured":"Damasio, A. R. On some functions of the human prefrontal cortex. Ann N Y Acad Sci 769, 241\u2013251 (1995).","journal-title":"Ann N Y Acad Sci"},{"key":"19154_CR58","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3233\/JAD-2006-9S311","volume":"9","author":"E Masliah","year":"2006","unstructured":"Masliah, E., Crews, L. & Hansen, L. Synaptic remodeling during aging and in Alzheimer\u2019s disease. J Alzheimers Dis 9, 91\u201399 (2006).","journal-title":"J Alzheimers Dis"},{"key":"19154_CR59","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1126\/science.1175509","volume":"326","author":"P Bonifazi","year":"2009","unstructured":"Bonifazi, P. et al. GABAergic hub neurons orchestrate synchrony in developing hippocampal networks. Science 326, 1419\u20131424 (2009).","journal-title":"Science"},{"key":"19154_CR60","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nn.3304","volume":"16","author":"G Buzsaki","year":"2013","unstructured":"Buzsaki, G. & Moser, E. I. Memory, navigation and theta rhythm in the hippocampal-entorhinal system. Nat Neurosci 16, 130\u2013138 (2013).","journal-title":"Nat Neurosci"},{"key":"19154_CR61","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1126\/science.1149381","volume":"321","author":"T Klausberger","year":"2008","unstructured":"Klausberger, T. & Somogyi, P. Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science 321, 53\u201357 (2008).","journal-title":"Science"},{"key":"19154_CR62","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0197-4580(95)00086-T","volume":"16","author":"P Dournaud","year":"1995","unstructured":"Dournaud, P., Delaere, P., Hauw, J. J. & Epelbaum, J. Differential correlation between neurochemical deficits, neuropathology, and cognitive status in Alzheimer\u2019s disease. Neurobiol Aging 16, 817\u2013823 (1995).","journal-title":"Neurobiol Aging"},{"key":"19154_CR63","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/2045-3701-3-19","volume":"3","author":"C Kelsom","year":"2013","unstructured":"Kelsom, C. & Lu, W. Development and specification of GABAergic cortical interneurons. Cell Biosci 3, 19 (2013).","journal-title":"Cell Biosci"},{"key":"19154_CR64","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1002\/gps.934","volume":"18","author":"PT Francis","year":"2003","unstructured":"Francis, P. T. Glutamatergic systems in Alzheimer\u2019s disease. Int J Geriatr Psychiatry 18, S15\u201321 (2003).","journal-title":"Int J Geriatr Psychiatry"},{"key":"19154_CR65","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000113713","volume":"5","author":"PT Francis","year":"2008","unstructured":"Francis, P. T. Glutamatergic approaches to the treatment of cognitive and behavioural symptoms of Alzheimer\u2019s disease. Neurodegener Dis 5, 241\u2013243 (2008).","journal-title":"Neurodegener Dis"},{"key":"19154_CR66","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.neuroscience.2015.01.007","volume":"323","author":"JJ Rodriguez-Arellano","year":"2016","unstructured":"Rodriguez-Arellano, J. J., Parpura, V., Zorec, R. & Verkhratsky, A. Astrocytes in physiological aging and Alzheimer\u2019s disease. Neuroscience 323, 170\u2013182 (2016).","journal-title":"Neuroscience"},{"key":"19154_CR67","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/(SICI)1097-4547(19990115)55:2<218::AID-JNR9>3.0.CO;2-L","volume":"55","author":"H Beckstrom","year":"1999","unstructured":"Beckstrom, H. et al. Interindividual differences in the levels of the glutamate transporters GLAST and GLT, but no clear correlation with Alzheimer\u2019s disease. J Neurosci Res 55, 218\u2013229 (1999).","journal-title":"J Neurosci Res"},{"key":"19154_CR68","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/00005072-199708000-00008","volume":"56","author":"S Li","year":"1997","unstructured":"Li, S., Mallory, M., Alford, M., Tanaka, S. & Masliah, E. Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. J Neuropathol Exp Neurol 56, 901\u2013911 (1997).","journal-title":"J Neuropathol Exp Neurol"},{"key":"19154_CR69","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.neuint.2006.10.007","volume":"50","author":"HS Walton","year":"2007","unstructured":"Walton, H. S. & Dodd, P. R. Glutamate-glutamine cycling in Alzheimer\u2019s disease. Neurochem Int 50, 1052\u20131066 (2007).","journal-title":"Neurochem Int"},{"key":"19154_CR70","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1126\/science.1097468","volume":"304","author":"RT Fremeau Jr","year":"2004","unstructured":"Fremeau, R. T. Jr et al. Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites. Science 304, 1815\u20131819 (2004).","journal-title":"Science"},{"key":"19154_CR71","doi-asserted-by":"publisher","first-page":"7158","DOI":"10.1073\/pnas.0401764101","volume":"101","author":"SM Wojcik","year":"2004","unstructured":"Wojcik, S. M. et al. An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size. Proc Natl Acad Sci USA 101, 7158\u20137163 (2004).","journal-title":"Proc Natl Acad Sci USA"},{"key":"19154_CR72","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1007\/s00429-014-0837-2","volume":"220","author":"N Heck","year":"2015","unstructured":"Heck, N. et al. A new automated 3D detection of synaptic contacts reveals the formation of cortico-striatal synapses upon cocaine treatment in vivo. Brain Struct Funct 220, 2953\u20132966 (2015).","journal-title":"Brain Struct Funct"},{"key":"19154_CR73","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuron.2005.11.032","volume":"49","author":"RW Daniels","year":"2006","unstructured":"Daniels, R. W. et al. A single vesicular glutamate transporter is sufficient to fill a synaptic vesicle. Neuron 49, 11\u201316 (2006).","journal-title":"Neuron"},{"key":"19154_CR74","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nn.2248","volume":"12","author":"S Schenck","year":"2009","unstructured":"Schenck, S., Wojcik, S. M., Brose, N. & Takamori, S. A chloride conductance in VGLUT1 underlies maximal glutamate loading into synaptic vesicles. Nat Neurosci 12, 156\u2013162 (2009).","journal-title":"Nat Neurosci"},{"key":"19154_CR75","doi-asserted-by":"publisher","first-page":"15544","DOI":"10.1523\/JNEUROSCI.2073-11.2011","volume":"31","author":"E Herzog","year":"2011","unstructured":"Herzog, E. et al. In vivo imaging of intersynaptic vesicle exchange using VGLUT1 Venus knock-in mice. J Neurosci 31, 15544\u201315559 (2011).","journal-title":"J Neurosci"},{"key":"19154_CR76","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1192\/bjp.140.6.566","volume":"140","author":"CP Hughes","year":"1982","unstructured":"Hughes, C. P., Berg, L., Danziger, W. L., Coben, L. A. & Martin, R. L. A new clinical scale for the staging of dementia. Br J Psychiatry 140, 566\u2013572 (1982).","journal-title":"Br J Psychiatry"},{"key":"19154_CR77","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1212\/WNL.48.6.1508","volume":"48","author":"JC Morris","year":"1997","unstructured":"Morris, J. C. et al. Clinical dementia rating training and reliability in multicenter studies: the Alzheimer\u2019s Disease Cooperative Study experience. Neurology 48, 1508\u20131510 (1997).","journal-title":"Neurology"},{"key":"19154_CR78","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.neurobiolaging.2006.02.010","volume":"28","author":"A Kashani","year":"2007","unstructured":"Kashani, A., Betancur, C., Giros, B., Hirsch, E. & El Mestikawy, S. Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease. Neurobiol Aging 28, 568\u2013578 (2007).","journal-title":"Neurobiol Aging"},{"key":"19154_CR79","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1111\/j.1460-9568.2004.03628.x","volume":"20","author":"E Herzog","year":"2004","unstructured":"Herzog, E. et al. Expression of vesicular glutamate transporters, VGLUT1 and VGLUT2, in cholinergic spinal motoneurons. Eur J Neurosci 20, 1752\u20131760 (2004).","journal-title":"Eur J Neurosci"},{"key":"19154_CR80","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1471-4159.1975.tb11895.x","volume":"24","author":"F Fonnum","year":"1975","unstructured":"Fonnum, F. A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem 24, 407\u2013409 (1975).","journal-title":"J Neurochem"},{"key":"19154_CR81","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0169-328X(92)90210-3","volume":"13","author":"C Llorens-cortes","year":"1992","unstructured":"Llorens-cortes, C., Bertherat, J., Jomary, C., Kordon, C. & Epelbaum, J. Regulation of somatostatin synthesis by GABAA receptor stimulation in mouse brain. Brain Res Mol Brain Res 13, 277\u2013281 (1992).","journal-title":"Brain Res Mol Brain Res"},{"key":"19154_CR82","unstructured":"Team, R. D. C. In R Foundation for Statistical Computing (2008)."},{"key":"19154_CR83","doi-asserted-by":"crossref","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis. Use R (2009).","DOI":"10.1007\/978-0-387-98141-3"},{"key":"19154_CR84","doi-asserted-by":"crossref","unstructured":"Kassambara, A. & Mundt, F. factoextra: Extract and Visualize the Results of Multivariate Data Analyses, http:\/\/www.sthda.com\/english\/rpkgs\/factoextra (2016).","DOI":"10.32614\/CRAN.package.factoextra"},{"key":"19154_CR85","unstructured":"Fox, J. Polychoric and Polyserial Correlations (2016)."},{"issue":"Pt 6","key":"19154_CR86","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1242\/jcs.112.6.811","volume":"112","author":"A Dumoulin","year":"1999","unstructured":"Dumoulin, A. et al. Presence of the vesicular inhibitory amino acid transporter in GABAergic and glycinergic synaptic terminal boutons. J Cell Sci 112(Pt 6), 811\u2013823 (1999).","journal-title":"J Cell Sci"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19154-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19154-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19154-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T12:31:59Z","timestamp":1719750719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19154-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,17]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["19154"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-19154-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,17]]},"assertion":[{"value":"17 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"938"}}